CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Myriad Genetics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Myriad Genetics, Inc.
322 North 2200 West
Phone: (801) 584-3600p:801 584-3600 SALT LAKE CITY, UT  84116  United States Ticker: MYGNMYGN
Business Summary
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes-YesYes

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board S. LouisePhanstiel 64 3/23/2020 9/16/2009
President, Chief Executive Officer, Director Paul J.Diaz 61 8/13/2020 8/13/2020
Chief Financial Officer, Principal Financial Officer Scott J.Leffler 48 1/29/2024 1/29/2024
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Gateway Genomics, LLC 7590 Fay Ave. La Jolla CA United States
Counsyl, Inc. 180 Kimball Way South San Francisco CA United States
Crescendo Bioscience 341 Oyster Point Blvd South San Francisco CA United States
AssureRx Health, Inc. 6030 S. Mason Montgomery Road Mason OH United States

Business Names
Business Name
AssureRx Canada, Ltd
AssureRx Health, Inc.
Assurex Health, Inc.
26 additional Business Names available in full report.

General Information
Number of Employees: 2,700 (As of 12/31/2023)
Outstanding Shares: 90,478,255 (As of 4/11/2024)
Shareholders: 95
Stock Exchange: NASD
Federal Tax Id: 870494517
Fax Number: (801) 584-3640
Email Address: investor@myriad.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024